Literature DB >> 9681719

The effect of uraemia, acidosis, and dialysis treatment on protein metabolism: a longitudinal leucine kinetic study.

V S Lim1, K E Yarasheski, M J Flanigan.   

Abstract

BACKGROUND: Uraemia and dialysis are viewed as catabolic processes resulting in malnutrition in chronic renal failure (CRF) patients. To sort out the effects of uraemia, acidosis, and dialysis on protein metabolism, we measured leucine flux in CRF patients before and after initiation of maintenance dialysis. SUBJECTS AND METHODS: Whole-body leucine flux was measured by primed-constant infusion of L[1-(13)C] leucine in nine CRF patients longitudinally; twice before and once after initiation of maintenance dialysis (D). Before dialysis, one leucine flux was measured when the patients were acidotic (A), and the other, when acidosis was corrected with NaHCO, (NA). Five normal subjects underwent one single leucine flux measurement to serve as control (N). Both patients and normal subjects consumed a constant diet for 6 days and leucine flux was measured on the 7th day 12 h post-absorption. Diet for the CRF patients was identical during the three periods. Plasma L[1-(13)C] leucine and L[1-(13)C]KIC were measured by gas chromatography/mass spectrometry and expired 13CO2 by isotope ratio spectrometry. Leucine kinetics were calculated using standard equations.
RESULTS: Plasma CO2 levels were 19, 26 and 31 mmol/l in A, NA and D periods respectively. All kinetic results (micromol/kg/h) are presented as means +/- SD in the order of A, NA, D, and N, and CRF values that are statistically different from N are identified (*). The amounts of leucine release from endogenous protein breakdown (Ra or Q) were 101 +/- 12* 95 +/- 9* 113 +/- 22 and 117 +/- 6. Leucine oxidation (C), quantities of leucine irreversibly oxidized to CO2, were 16.5 +/- 5.4, 9.7 +/- 3.7*, 12.3 +/- 3.0*, and 23.2 +/- 3.1. Leucine protein incorporation levels (S) were 85 +/- 10, 85 +/- 8, 101 +/- 19 and 94 +/- 6. The S of 101 in CRF patients at period D was statistically higher than those during A and NA periods.
CONCLUSIONS: These data indicate that when acidosis was corrected, CRF patients adapted to lower protein intake by reducing amino-acid oxidation and protein degradation, and maintained protein synthesis at normal levels. Metabolic acidosis impaired the downregulation of amino-acid oxidation. Maintenance dialysis treatment longitudinally restored protein flux to normal and increased protein synthesis. The general notion that uraemia and dialysis are protein catabolic is not supported by this work.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681719     DOI: 10.1093/ndt/13.7.1723

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

1.  Acid-base balance and physical function.

Authors:  Matthew K Abramowitz
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-07       Impact factor: 8.237

2.  Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients.

Authors:  T Lau; W Owen; Y M Yu; N Noviski; J Lyons; D Zurakowski; R Tsay; A Ajami; V R Young; L Castillo
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

3.  Hormonal regulation of energy-protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes.

Authors:  Manish Suneja; Daryl J Murry; John B Stokes; Victoria S Lim
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-19       Impact factor: 4.310

4.  Skeletal muscle fibrosis is associated with decreased muscle inflammation and weakness in patients with chronic kidney disease.

Authors:  Matthew K Abramowitz; William Paredes; Kehao Zhang; Camille R Brightwell; Julia N Newsom; Hyok-Joon Kwon; Matthew Custodio; Rupinder S Buttar; Hina Farooq; Bushra Zaidi; Rima Pai; Jeffrey E Pessin; Meredith Hawkins; Christopher S Fry
Journal:  Am J Physiol Renal Physiol       Date:  2018-10-03

Review 5.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

6.  Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function.

Authors:  Flore Duranton; Ulrika Lundin; Nathalie Gayrard; Harald Mischak; Michel Aparicio; Georges Mourad; Jean-Pierre Daurès; Klaus M Weinberger; Angel Argilés
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

7.  Effect of high-normal compared with low-normal arterial pH on protein balances in automated peritoneal dialysis patients.

Authors:  Rajnish Mehrotra; Rachelle Bross; Huiyuan Wang; Marilyn Appell; Lai Tso; Joel D Kopple
Journal:  Am J Clin Nutr       Date:  2009-10-21       Impact factor: 7.045

8.  Nutrition support for the chronically wasted or acutely catabolic chronic kidney disease patient.

Authors:  T Alp Ikizler
Journal:  Semin Nephrol       Date:  2009-01       Impact factor: 5.299

9.  Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality.

Authors:  Tania Vashistha; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Klara Torlén; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-26       Impact factor: 8.237

Review 10.  Muscle-bone axis in children with chronic kidney disease: current knowledge and future perspectives.

Authors:  Vasiliki Karava; John Dotis; Athanasios Christoforidis; Antonia Kondou; Nikoleta Printza
Journal:  Pediatr Nephrol       Date:  2021-02-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.